Symbols

BBLG

Bone Biologics·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 1

Stock Price Surged Significantly

Ample Liquidity

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About BBLG

Bone Biologics Corporation

A medical device company that focuses on bone regeneration in spinal fusion

Industry

Healthcare Equipment and Supplies

Established Date

10/18/2007

Listing Date

10/13/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.bonebiologis.com

Security Type

Common stock

Office address

2 Burlington Woods Drive, Suite 100, Burlington, MA 01803

Business

Introduction

Bone Biologics Corporation was incorporated in Delaware on October 18, 2007. The company is a medical device company currently focusing on bone regeneration in spinal fusion using recombinant human proteins. The company's platform technology has been applied to surgical specialties such as spine, orthopedics, general orthopedics, plastic reconstruction, neurosurgery, interventional radiology and sports medicine and provides better results.

Company Financials

EPS

BBLG has released its 2023 Q3 earnings. EPS was reported at -4.88, versus the expected -0.61, missing expectations. The chart below visualizes how BBLG has performed over recent quarters, highlighting trends in earnings surprises.